Találati lista | Tudóstér

001-es BibID:	BIBFORM088520
035-os BibID:	(cikkazonosító)E7686 (scopus)85092599352 (wos)000583012300001
Első szerző:	Bozóki Beáta (molekuláris biológus)
Cím:	Specificity Studies of the Venezuelan Equine Encephalitis Virus Non-Structural Protein 2 Protease Using Recombinant Fluorescent Substrates / Bozóki Beáta, Mótyán János András, Hoffka Gyula, Waugh David S., Tőzsér József
Dátum:	2020
ISSN:	1661-6596 1422-0067
Megjegyzések:	The non-structural protein 2 (nsP2) of alphavirus Venezuelan equine encephalitis virus (VEEV) is a cysteine protease that is responsible for processing of the viral non-structural polyprotein and is an important drug target owing to the clinical relevance of VEEV. In this study we designed two recombinant VEEV nsP2 constructs to study the effects of an N-terminal extension on the protease activity and to investigate the specificity of the elongated enzyme in vitro. The N-terminal extension was found to have no substantial effect on the protease activity. The amino acid preferences of the VEEV nsP2 protease were investigated on substrates representing wild-type and P5, P4, P2, P1, P1·, and P2· variants of Semliki forest virus nsP1/nsP2 cleavage site, using a His6-MBP-mEYFP recombinant substrate-based protease assay which has been adapted for a 96-well plate-based format. The structural basis of enzyme specificity was also investigated in silico by analyzing a modeled structure of VEEV nsP2 complexed with oligopeptide substrate. To our knowledge, in vitro screening of P1· amino acid preferences of VEEV nsP2 protease remains undetermined to date, thus, our results may provide valuable information for studies and inhibitor design of different alphaviruses or other Group IV viruses.
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk VEEV Venezuelan equine encephalitis virus nsp2 protease alphavirus alphaviral protease non-structural protein group IV virus specificity
Megjelenés:	International Journal Of Molecular Sciences. - 21 : 20 (2020), p. 1-26. -
További szerzők:	Mótyán János András (1981-) (biokémikus, molekuláris biológus) Hoffka Gyula (1992-) (vegyész) Waugh, David S. Tőzsér József (1959-) (molekuláris biológus, biokémikus, vegyész)
Pályázati támogatás:	NKFI-125238 Egyéb GINOP-2.3.2-15-2016-00044 GINOP TÁMOP 4.2.4B/2-11/1-2012-0001 Egyéb NKFIH-1150-6/2019 Egyéb
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM108790
035-os BibID:	(Scopus)85148381582 (WoS)000944102100001
Első szerző:	Hoffka Gyula (vegyész)
Cím:	Self-inhibited state of Venezuelan equine encephalitis virus (VEEV) nsP2 cysteine protease : a crystallographic and molecular dynamics analysis / Gyula Hoffka, George T. Lountos, Danielle Needle, Alexander Wlodawer, David S. Waugh, József Tőzsér, János András Mótyán
Dátum:	2023
ISSN:	0022-2836
Megjegyzések:	The Venezuelan equine encephalitis virus (VEEV) belongs to the Togaviridae family and is pathogenic to both humans and equines. The VEEV non-structural protein 2 (nsP2) is a cysteine protease (nsP2pro) that processes the polyprotein and thus it is a drug target for inhibitor discovery. The atomic structure of the VEEV nsP2 catalytic domain was previously characterized by both X-ray crystallography and computational studies. A modified nsP2pro harboring a N475A mutation in the N terminus was observed to exhibit an unexpected conformation: the N-terminal residues bind to the active site, mimicking binding of a substrate. The large conformational change of the N terminus was assumed to be induced by the N475A mutation, as N475 has an important role in stabilization of the N terminus and the active site. This conformation was first observed in the N475A mutant, but we also found it while determining a crystal structure of the catalytically active nsP2pro containing the wild-type N475 active site residue and K741A/K767A surface entropy reduction mutations. This suggests that the N475A mutation is not a prerequisite for self-inhibition. Here, we describe a high resolution (1.46 ?A) crystal structure of a truncated nsP2pro (residues 463-785, K741A/K767A) and analyze the structure further by molecular dynamics to study the active and self-inhibited conformations of nsP2pro and its N475A mutant. A comparison of the different conformations of the N-terminal residues sheds a light on the interactions that play an important role in the stabilization of the enzyme.
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk Venezuelan equine encephalitis virus protease alphavirus crystallography molecular dynamics
Megjelenés:	Journal Of Molecular Biology. - 435 : 6 (2023), p. 1-20. -
További szerzők:	Lountos, George T. Needle, Danielle Wlodawer, Alexander Waugh, David S. Tőzsér József (1959-) (molekuláris biológus, biokémikus, vegyész) Mótyán János András (1981-) (biokémikus, molekuláris biológus)
Pályázati támogatás:	TKP2021-EGA-20 (Biotechnology) Egyéb
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM101151
035-os BibID:	(cikkazonosító)3507 (scopus)85126818776 (wos)000781388600001
Első szerző:	Mótyán János András (biokémikus, molekuláris biológus)
Cím:	Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors : lessons Learned from HIV-1 Protease / János András Mótyán, Mohamed Mahdi, Gyula Hoffka, József Tőzsér
Dátum:	2022
ISSN:	1661-6596 1422-0067
Megjegyzések:	Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome 2 (SARS-CoV-2), has been one of the most devastating pandemics of recent times. The lack of potent novel antivirals had led to global health crises; however, emergence and approval of potent inhibitors of the viral main protease (Mpro), such as Pfizer's newly approved nirmatrelvir, offers hope not only in the therapeutic front but also in the context of prophylaxis against the infection. By their nature, RNA viruses including human immunodeficiency virus (HIV) have inherently high mutation rates, and lessons learnt from previous and currently ongoing pandemics have taught us that these viruses can easily escape selection pressure through mutation of vital target amino acid residues in monotherapeutic settings. In this paper, we review nirmatrelvir and its binding to SARS-CoV-2 Mpro and draw a comparison to inhibitors of HIV protease that were rendered obsolete by emergence of resistance mutations, emphasizing potential pitfalls in the design of inhibitors that may be of important relevance to the long-term use of novel inhibitors against SARS-CoV-2.
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk SARS-CoV-2 coronavirus HIV-1 protease 3CLpro Mpro nirmatrelvir protease inhibitor PF-07321332 Paxlovid drug resistance resistance
Megjelenés:	International Journal Of Molecular Sciences. - 23 : 7 (2022), p. 1-20. -
További szerzők:	Mahdi, Mohamed (1979-) (orvos, tudományos segédmunkatárs) Hoffka Gyula (1992-) (vegyész) Tőzsér József (1959-) (molekuláris biológus, biokémikus, vegyész)
Pályázati támogatás:	TKP2021-EGA-20 Egyéb
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: